{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:00:47Z","timestamp":1791900047204,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1038\/ng0398-283","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:25:30Z","timestamp":1092860730000},"page":"283-286","source":"Crossref","is-referenced-by-count":253,"title":["Epistatic relationship between Waardenburg Syndrome genes MITF and PAX3"],"prefix":"10.1038","volume":"18","author":[{"given":"Atsushi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ploplis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng0398283_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jmg.34.8.656","volume":"34","author":"AP Read","year":"1997","unstructured":"Read, A.P. & Newton, V.E. Waardenburg syndrome. J. Med. Genet. 34, 656\u2013665 (1997).","journal-title":"J. Med. Genet."},{"key":"BFng0398283_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ng0996-50","volume":"14","author":"M Tachibana","year":"1996","unstructured":"Tachibana, M. et al. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nature Genet. 14, 50\u201354 (1996).","journal-title":"Nature Genet."},{"key":"BFng0398283_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/1044-7431(92)90055-7","volume":"3","author":"M Tachibana","year":"1992","unstructured":"Tachibana, M. et al. Cochlear disorder associated with melanocyte anomaly in mice with a transgenic insertional mutation. Mol. Cell. Neurosci. 3, 433\u2013445 (1992).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFng0398283_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng1194-251","volume":"8","author":"M Tassabehji","year":"1994","unstructured":"Tassabehji, M., Newton, V.E. & Read, A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet. 8, 251\u2013255 (1994).","journal-title":"Nature Genet."},{"key":"BFng0398283_CR5","first-page":"76","volume":"59","author":"Y Nobukuni","year":"1996","unstructured":"Nobukuni, Y., Watanabe, A., Takeda, K., Skarka, H. & Tachibana, M. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am. J. Hum. Genet. 59, 76\u201383 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng0398283_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJM199601043340108","volume":"334","author":"DS Latchman","year":"1996","unstructured":"Latchman, D.S. Transcription-factor mutations and disease. N. Engl. J. Med. 334, 28\u201333 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFng0398283_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/humu.1380030304","volume":"3","author":"GL Semenza","year":"1994","unstructured":"Semenza, G.L. Transcriptional regulation of gene expression: mechanisms and pathophysiology. Hum. Mutat. 3, 180\u2013199 (1994).","journal-title":"Hum. Mutat."},{"key":"BFng0398283_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/355635a0","volume":"355","author":"M Tassabehji","year":"1992","unstructured":"Tassabehji, M. et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635\u2013636 (1992).","journal-title":"Nature"},{"key":"BFng0398283_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/355637a0","volume":"355","author":"CT Baldwin","year":"1992","unstructured":"Baldwin, C.T., Hoth, C.F., Amos, J.A., da-Silva, E.O. & Milunsky, A. An exonic mutation in the Hup2 paired domain gene causes Waardenburg's syndrome. Nature 355, 637\u2013638 (1992).","journal-title":"Nature"},{"key":"BFng0398283_CR10","first-page":"455","volume":"52","author":"CF Hoth","year":"1993","unstructured":"Hoth, C.F. et al. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455\u2013462 (1993).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng0398283_CR11","first-page":"75","volume":"56","author":"AK Lalwani","year":"1995","unstructured":"Lalwani, A.K. et al. Further elucidation of the genomic structure of PAX3, and identification of two different point mutations within the PAX3 homeobox that cause Waardenburg syndrome type I in two families. Am. J. Hum. Genet. 56, 75\u201383 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng0398283_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/hmg\/4.11.2131","volume":"4","author":"M Tassabehji","year":"1995","unstructured":"Tassabehji, M. et al. The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet. 4, 2131\u20132137 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"BFng0398283_CR13","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1073\/pnas.91.9.3685","volume":"91","author":"G Chalepakis","year":"1994","unstructured":"Chalepakis, G., Goulding, M., Read, A., Strachan, T. & Gruss, P. Molecular basis of splotch and Waardenburg syndrome Pax-3 mutations. Proc. Natl. Acad. Sci. USA 91, 3685\u20133689 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0398283_CR14","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.93.9.4213","volume":"93","author":"JA Epstein","year":"1996","unstructured":"Epstein, J.A., Shapiro, D.N., Chen, J., Lam, P.Y.P. & Maas, R.L. Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. USA 93, 4213\u20134218 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0398283_CR15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1242\/dev.124.12.2377","volume":"124","author":"K Opdecamp","year":"1997","unstructured":"Opdecamp, K. et al. Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124, 2377\u20132386 (1997).","journal-title":"Development"},{"key":"BFng0398283_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1006\/bbrc.1996.0298","volume":"219","author":"N Fuse","year":"1996","unstructured":"Fuse, N., Yasumoto, K., Suzuki, H., Takahashi, K. & Shibahara, S. Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem. Biophys. Res. Comm. 219, 702\u2013707 (1996).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"BFng0398283_CR17","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1093\/nar\/22.15.3131","volume":"22","author":"G Chalepakis","year":"1994","unstructured":"Chalepakis, G., Wijnholds, J. & Gruss, P. Pax-3-DNA interaction: flexibility in the DNA binding and induction of DNA conformational changes by paired domains. Nucleic Acids Res. 22, 3131\u20133137 (1994).","journal-title":"Nucleic Acids Res."},{"key":"BFng0398283_CR18","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1002\/j.1460-2075.1994.tb06636.x","volume":"13","author":"S Guazzi","year":"1994","unstructured":"Guazzi, S. et al. The thyroid transcription factor-1 gene is a candidate target for regulation by Hox proteins. EMBO J. 13, 3339\u20133347 (1994).","journal-title":"EMBO J."},{"key":"BFng0398283_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0888-7543(95)80076-X","volume":"26","author":"RA Macina","year":"1995","unstructured":"Macina, R.A., Barr, F.G., Galili, N. & Riethman, H.C. Genomic organization of the human PAX3 gene: DNA sequence analysis of the region disrupted in alveolar rhabdomyosarcoma. Genomics 26, 1\u20138 (1995).","journal-title":"Genomics"},{"issue":"15","key":"BFng0398283_CR20","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","volume":"17","author":"Edgar Schreiber","year":"1989","unstructured":"Schreiber, E., Matthias, P., M\u00fcller, M.M. & Schaffner, W. Rapid detection of octamer binding proteins with \u2018mini-extracts\u2019, prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).","journal-title":"Nucleic Acids Research"},{"key":"BFng0398283_CR21","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1128\/MCB.15.3.1522","volume":"15","author":"WJ Fredericks","year":"1995","unstructured":"Fredericks,W.J. et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 1522\u20131535 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"BFng0398283_CR22","first-page":"178","volume":"8","author":"DH Jones","year":"1990","unstructured":"Jones, D.H. & Howard, B.H. A rapid method for the site-specific mutagenesis and directional subcloning by using the polymerase chain reaction to generate recombinant circles. BioTechniques 8, 178\u2013183 (1990).","journal-title":"BioTechniques"},{"key":"BFng0398283_CR23","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1128\/MCB.13.9.5206","volume":"13","author":"Y Kamachi","year":"1993","unstructured":"Kamachi, Y. & Kondoh, H. Overlapping positive and negative regulatory elements determine lens-specific activity of the \u03b41-crystallin enhancer. Mol. Cell. Biol. 13, 5206\u20135215 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"BFng0398283_CR24","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1073\/pnas.88.12.5167","volume":"88","author":"T Miki","year":"1991","unstructured":"Miki, T. et al. Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc. Natl. Acad. Sci. USA 88, 5167\u20135171 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0398283_CR25","first-page":"545","volume":"11","author":"JE Sublett","year":"1995","unstructured":"Sublett, J.E., Jeon, I.-S. & Shapiro, D.N. The alveolar rhabdomyosarcoma PAX3\/FKHR fusion protein is a transcriptional activator. Oncogene 11, 545\u2013552 (1995).","journal-title":"Oncogene"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0398-283","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0398-283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0398-283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:26:17Z","timestamp":1684441577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0398-283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BFng0398283"],"URL":"https:\/\/doi.org\/10.1038\/ng0398-283","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}